Arterial endothelial cells (EC) at the adult stage differ from capillary and venous EC in terms of resistance to stress; however, the molecular basis of this resistance is not clear. Here, we found that arterial EC are highly resistant to bone morphogenetic protein (BMP)4-dependent apoptosis, whereas capillary and venous EC are not. The expression of inhibitory Smads (I-Smads) in arterial EC was well correlated with the resistance to this apoptosis. After the knockdown of I-Smad expression by short interfering RNA, the resistant arterial EC became sensitive to BMP4. In contrast, the ectopic expression of I-Smads in BMP4-sensitive cells suppressed BMP4-induced apoptosis. Furthermore, intravenous administration of BMP4 into mice caused hemorrhage of capillary EC in brain and lung. These results strongly suggest that BMP4/I-Smads are a novel regulator for the stability of vascular EC.
Introduction
The closed circular system in vertebrates is fundamental to the regulation of organ development, maintenance and regression, supplying nutrients and oxygen. During embryogenesis, a dynamic remodeling of blood vessel structures takes place by proangiogenic and antiangiogenic factors such as vascular endothelial growth factor (VEGF), angiopoietin (Ang) and the transforming growth factor b (TGFb) superfamily. In the remodeling process, endothelial cells (EC) differentiate into several cell types such as arterial, venous and capillary cells. VEGF regulates vasculogenesis and angiogenesis from the earliest stage of embryogenesis, and further regulates vascular remodeling and hematopoiesis. The Ang-Tie2 receptor system plays a crucial role in the interaction between EC and smooth muscle cells (Yancopoulos et al., 1998; Shibuya et al., 1999; Shibuya, 2001; Patan, 2004) . The TGFb superfamily is also suggested to regulate vascular remodeling, but the processes involved are not fully understood except for hereditary hemorrhagic telangiectasia type 1 (or OslerWeber-Rendu syndrome) (Bourdeau et al., 2000; Duff et al., 2003) .
The TGFb superfamily consists of a diverse group of structurally related proteins, including TGFbs, activins, bone morphogenetic proteins (BMPs) and others (Massague, 1998) . These cell-cell signaling molecules participate in a variety of biological processes ranging from the regulation of cell migration, proliferation, differentiation and apoptosis. They also specify distinct cell fates and the patterning of organ systems in embryogenesis. The members of this superfamily are known to have different effects depending on the type and state of the cell in various organs.
We have recently shown that vascular EC in the rat pupillary membrane, a temporary capillary network in the anterior chamber of the lens, are postnatally regressed mostly via apoptosis dependent on BMP4, which is transiently secreted from matured lens epithelial cells (Kiyono and Shibuya, 2003) . Although this phenomenon is one example of the regression of a capillary network in a developmentally programmed manner, it is not clear whether any difference exists in the BMP4-induced apoptosis among different types of EC. Furthermore, BMP4 signal transduction pathways and the molecular nature of their components have been studied in detail, but the signaling cascade by which BMP4 induces apoptosis both in vivo and in vitro is not fully understood.
Here, we demonstrated that BMP4 efficiently induces apoptosis only in limited types of EC such as microvascular EC and human umbilical vein EC (HUVEC), and that the arterial EC including coronary arterial EC are highly resistant to BMP4. Furthermore, the resistance to BMP4 well correlates with the expression levels of inhibitory Smads (I-Smads), and the I-Smads appear to be the direct regulator for this phenomenon.
Results

Different effects of BMP4 on non-immortalized human EC
We previously showed that BMP4 promotes the apoptosis of capillary EC in papillary membrane (PM) (Kiyono and Shibuya, 2003) . In an attempt to know whether BMP4-induced apoptosis is a common feature of vascular EC, we tested the effect of BMP4 on various human EC by means of TdT-mediated dUTP nick end labeling and Trypan blue staining assays. BMP4 dose-dependently and selectively induced apoptosis of HUVEC and human dermal microvascular EC (HMVEC) (Figure 1a) . Interestingly, however, it did not induce apoptosis of mature arterial EC such as human aortic EC (HAEC) and human coronary artery EC (HCAEC). These EC are highly resistant to BMP4 even at a concentration of 100 ng/ml. Unlike BMP4, BMP7 had no apoptosis-inducing effect on EC under the same conditions (Figure 1b) . We confirmed that this BMP7 induces phosphorylation of Smad1 in dose-and time-dependent manners (data not shown). On treatment with BMP4, a marked apoptosis of HUVEC and HMVEC, but not HAEC or HCAEC, was induced in a timedependent manner (Figure 1c and d) . Essentially, the same results were obtained by means of flow cytometry, showing the appearance of a hypodiploid DNA peak and increase in the proportion of apoptotic cells (Figure 1e-h) .
To clarify the mechanism of the BMP4-induced effects on cell type-specific apoptosis, we examined the expression of various mRNAs, including the VEGF receptor (VEGFR) family and the molecules of the BMP signaling pathway by reverse transcriptionpolymerase chain reaction (RT-PCR). As shown in Figure 2 , levels of the VEGFR family and most of the other genes examined were not significantly altered among EC. However, the I-Smads, Smad6 and Smad7, were expressed strongly in BMP4-insensitive EC, HAEC and HCAEC, but only weakly in BMP4-sensitive cells such as HUVEC and HMVEC. In addition, BMP4 did not change the levels of I-Smads in HUVEC for 1-4 days culture (data not shown). Therefore, the levels of I-Smads were well correlated with the resistance to BMP4-induced apoptosis.
Inhibition of BMP4-induced apoptosis by Smad6 and Smad7 (I-Smads) It has been shown that Smad6 and Smad7 are negative regulators of the Smad1, Smad5 and Smad8 signaling cascade initiated by BMPs (Imamura et al., 1997; Souchelnytskyi et al., 1998) . We hypothesized that I-Smads also negatively regulated BMP4-induced apoptotic signals in EC. To test the hypothesis, we transiently expressed I-Smads by transfecting expression vectors encoding Flag-tagged Smad6 or Smad7 into HUVEC, and investigated the effect of elevated I-Smad levels on the intracellular signaling. Expression of these proteins was confirmed by immunoblot analysis with anti-Flag antibody (Figure 3a ). HUVEC transfected with the above vectors were stimulated with BMP4 for 24 h, then subjected to Trypan blue staining and TUNEL labeling assays. Notably, most of the transfected HUVEC became resistant to BMP4. Only a few apoptotic cells were detected in these HUVEC, whereas treatment of and HUVEC (g, h) were cultured with (f, h) or without (e, g) BMP4 (100 ng/ml) for 18 h. Cells were fixed and stained with propidium iodide (PI) before being used for fluorescence-activated cell sorting analysis to determine DNA content. Results are representative of several experiments.
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Short interfering RNA to I-Smads rescues the proapoptotic effect of BMP4 on resistant EC To further examine whether the inhibition of endogenous Smad6 and Smad7 is sufficient to induce BMP4-mediated apoptosis in EC, we used the short interfering RNA (siRNA) system to knock down their endogenous expression. HAEC transfected with I-Smad siRNAs (siSmad6 and siSmad7) or mutant siRNAs (siSmad6m and siSmad7m) were cultured in the presence or absence of BMP4 for 24 h, and subsequently analysed with Trypan blue staining and TUNEL labeling assays ( Figure 4a ). After knockdown of the endogenous expression of I-Smads in HAEC, BMP4 efficiently induced apoptosis in arterial EC ( Figure 4b ). As a control, I-Smad-mutant siRNAs did not make the arterial EC sensitive to BMP4 (Figure 4b ). Furthermore, suppression of Smad6 and/or Smad7 in HAEC caused BMP4-mediated processing and activation of caspase 3 (Figure 4c ). These results clearly indicate that I-Smads play a major role in the negative regulation of BMP4-induced apoptosis in the vascular system.
Specific influence of BMP4 on vascular EC in mice
Finally, to determine the specific sensitivity of various EC to BMP4 in vivo, we injected BMP4 intravenously into mice. After 2 days, the mice injected with BMP4 often exhibited brain hemorrhage macroscopically, compared with the control mice administered phosphate-buffered saline (PBS) (Figure 5a) . A detailed histological analysis revealed typical subarachnoid hemorrhage in the brains from BMP4-injected mice ( Figure 5b ). Moreover, EC in the hemorrhagic area frequently showed TUNEL-positive signals (Figure 5d ). In addition, BMP4 induced severe hemorrhage into the alveolar space in the lung (Figure 5c ). Therefore, BMP4 appears to attack EC, especially capillary-like EC, to induce apoptosis following hemorrhage in vivo; however, arterial EC in the body were essentially resistant to BMP4. Altogether, these observations clearly showed that BMP4 selectively induces the apoptosis of EC depending BMP4-induced EC apoptosis regulated by I-Smads M Kiyono and M Shibuya on the expression of I-Smads. Thus, I-Smads may be a novel important regulator of whether certain EC undergo apoptosis or not.
Discussion
BMP4-induced apoptosis has been analysed extensively, especially in developing chickens (Graham et al., 1994; Zou and Niswander, 1996) . Although the BMP4 signal transduction pathways and molecular nature of their components have been studied in detail, the signaling cascade by which BMP4 induces apoptosis both in vivo and in vitro is not fully understood. Here, we clearly showed that BMP4-induced apoptosis in vascular EC is dependent on the expression of I-Smads in each type of cells. In the case of BMP2, exogenously expressed Smad6 was reported to suppress BMP2-induced apoptosis in several cell lines (Imamura et al., 1997; Nakao et al., 1997; Hata et al., 1998; Ishisaki et al., 1999; Kimura et al., 2000) . Therefore, I-Smads are a reasonable candidate for the negative regulator in the apoptotic signaling of BMP4 in EC. With respect to the mechanisms that relate to the proapoptotic effect of BMP4 on HUVEC, we focused on Smad6 and/or Smad7 expression in these cells. Here, we have provided direct evidence that BMP4-promoted endothelial apoptosis is dependent on the expression of I-Smads by using an siRNA system for I-Smads and by exogenous expression of I-Smads (Figures 3  and 4) .
Several important questions still remain to be answered regarding the I-Smad-dependent regulation of BMP4-induced EC apoptosis. First, what is the molecular basis of upregulation of I-Smad mRNA expression in certain types of EC, particularly mature arterial EC? If the high level of I-Smad mRNA in these cells is mainly owing to transcriptional activation and not stabilization of the mRNA, which transcription factor(s) is involved in this phenotype?
The VEGF-VEGFR system is known to regulate both arterial and venous blood vessel formation. On the other hand, ephrinB2 is expressed in arterial EC, whereas EphB4 is expressed in venous EC, and this separated expression induces physiological remodeling of the arterial-venous system (Wang et al., 1998; Shin et al., 2001) . Neuropilin-1 (NRP-1) is also expressed strongly in arterial EC but only weakly in venous EC (Herzog et al., 2001; Moyon et al., 2001) . Furthermore, activation of the Delta-Notch pathway in arterial EC was indicated to be critical for upregulation of the expression of the ephrinB2 and NRP-1 genes in arterial EC (Shawber et al., 2003) . Therefore, the DeltaNotch pathway is a good candidate for the transcriptional activator of I-Smad genes in arterial EC. In addition, le Noble et al. (2004) reported that arterialvenous EC at early embryogenesis show flexibility in the fate of changing shear stress. Notably, in human vascular EC, the expression of I-Smad genes is selectively induced by shear stress (Topper et al., 1997) . Thus, arterial differentiation and a mechanochemical stimulus could be two major determinants of I-Smad expression.
Although most of the results obtained in this study are consistent with the Delta-Notch model in arteries, we found that human umbilical artery EC (HUAEC) expressed a lower level of I-Smads compared with HAEC, and their sensitivity to BMP4 was intermediate between resistant and sensitive EC (Figures 1 and 2) . It is not yet clear whether the intermediate phenotype of HUAEC is owing to a lack of shear stress under the culture conditions or the flexibility to change from an arterial to venous/capillary EC phenotype in umbilical tissues.
The second question is with regard to the physiological significance of I-Smad expression and BMP4 resistance in mature arterial EC but not in capillary or umbilical arterial EC. We suggest that this is important for (1) stable functioning of mature arterial EC, and (2) BMP4-induced EC apoptosis regulated by I-Smads M Kiyono and M Shibuya maintain some flexibility for remodeling and transient angiogenesis. Therefore, low levels of I-Smads in capillary/venous EC may be important for maintaining dynamism in the peripheral blood vessel system including the rodent pupillary membrane in the eye. Finally, we found that intravenous administration of BMP4 to mice caused hemorrhage in brain and lung ( Figure 5 ). But why only the brain and lung showed a hemorrhagic response? We suggest that several tissues such as the subarachnoid region and lung have a weaker vascular structure in terms of cellularity in the tissues surrounding vessels; thus, the microvessels in these tissues tend to under go hemorrhage after partial apoptosis of EC. It is important to examine whether or not some apoptotic damage (hemorrhagic disease) in the arterial wall including arterial EC is due to a loss of resistance of arterial EC to apoptosis-inducible cytokines such as BMP4. (Gu et al., 1996; Kiyono and Shibuya, 2003) .
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Materials and methods
Materials
Assessment of apoptosis
Apoptotic cells were detected using a TUNEL labeling kit (In situ cell death detection kit, fluorescein, Roche Diagnostics Co., Basel, Switzerland) according to the manufacturer's instructions. To assess the nuclear morphology of the cells, the samples were stained with Ho¨echst 33258 (Wako, Tokyo, Japan). The specimens were then observed under a fluorescence microscope. For determining the time course of apoptosis, cells were stained with Trypan blue and the positive cells were enumerated.
Plasmids and transfections
The Smad6 and Smad7 expression plasmids, pcDNA3-FLAGSmad6 and pcDNA3-FLAG-Smad7, were kindly provided by Dr K Miyazono (Hanyu et al., 2001) . HUVEC were transfected with plasmid using an HUVEC Nucleofector Kit (Amaxa Biosystems, Cologne, Germany).
Immunoblotting Immunoblotting was performed as described previously (Kiyono and Shibuya, 2003) .
Flow cytometry
For analyses of the cell cycle and apoptosis, DNA content was measured by PI staining with cytometry. After treatments, cells were trypsinized, collected by centrifugation and fixed in 70% (vol/vol) ethanol. The fixed cells were stained with 50 mg/ml PI before analysis by flow cytometry (FACsorter; Becton Dickinson, Flanklin Lakes, NJ, USA). The instrument was set to collect 2 Â 10 4 cells and the cell cycle profile was analysed using CellQuest software.
siRNA transfections
The siRNA sequences of Smad6 and Smad7 corresponded to regions 2672-2690 and 1353-1371 relative to the start codon, respectively. The sequences of each siRNA pair were as follows: siSmad6 (5 0 -GACGCACUUUGGCUUAUAATT-3 0 , 5 0 -UUAUAAGCCAAAGUGCGUCTT-3 0 ) and siSmad7 (5 0 -GGACGCUGUUGGUACACAATT-3 0 , 5 0 -UUGUGUACC AACAGCGUCCTT-3 0 ). Mismatched siRNAs against Smad6 and Smad7 were also designed as follows: siSmad6mut (5 0 -GACGCAgUUUGcCUUAUAATT-3 0 , 5 0 -UUAUAAGgCA AAcUGCGUCTT-3 0 ) and siSmad7mut (5 0 -GGACGCUGUU cGUAgACAATT-3 0 , 5 0 -UUGUcUACgAACAGCGUCCTT-3 0 ). Transfection of duplex siRNAs was performed using TransIT-TKO (Mirus Bio Corp., Madison, WI, USA) according to the manufacturer's directions. Two days after transfection, the efficacy of the knockdown was assessed by RT-PCR.
Intravenous administration of BMP4
Age-matched (5 weeks) female BALB/c CrSlc mice were obtained from SLC Inc. (Hamamatsu, Japan). BMP4 was dissolved in PBS and 100 ng/g was injected intravenously. For control injections, PBS was used. Two days later, the mice were perfused and organs were removed.
Immunohistochemistry
Organs of mice were fixed in 4% formaldehyde and paraffin sections were immunohistochemically incubated with the antihuman von Willebrand factor or TUNEL reagent.
